Healthcare
REGN
Regeneron Pharmaceuticals, Inc.
$784.36+1.59%
Add to Watchlist
About Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals makes drugs for eye diseases, allergies, cancer, and inflammation. Their biggest product, Eylea, treats age-related vision loss. The company is known for strong research capabilities and has developed multiple successful drugs from its own labs.
Full research is for ConvictionStocks members
Unlock Full AccessWhat Analysts Think
Full research is for ConvictionStocks members
Unlock Full AccessRecent News
Full research is for ConvictionStocks members
Unlock Full AccessGet the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Related Research
More Healthcare stocks to explore